Immunomedics, Inc.

Director, Financial Planning and Corporate Controller

US-NJ-Morris Plains
1 month ago
Job ID
# of Openings


Prepares and issues consolidated financial reports to SEC and shareholders and internal reports to Senior Management. Oversees and maintains policies and internal controls to ensure compliance with GAAP, SEC requirements, and Sarbanes-Oxley standards. Directs contact with external auditors, legal counsel, banking organizations, and financial consultants in regard to accounting or financial activities. Supervises accounting activities and provides overall guidance and direction of the finance and accounting functions for the Company. Assists the Vice President, Finance and CFO in management of the finance function.


  • Supervises and files the financial statements, footnotes, and MD&A disclosures for SEC financial reporting on a quarterly basis (Form 10-Q) and annual audit (Form 10-K) on a timely basis. Prepares responses to SEC letters and comments.
  • Reviews the consolidated financial statements and coordinates monthly financial reporting activities for Senior Management review, including variance analysis.
  • Directs the preparation of the Annual Budget with supporting details for Senior Management and the Board of Directors, including analysis of departmental submissions.
  • Directs activities with external auditors during the year and supervises work with external auditors in regard to requirements for the year-end audit of the financial statements.
  • Ensures accounting processes and internal controls are in place and documented in accordance with Sarbanes-Oxley 404 requirements. Reviews and provides quality control assessments on Section 404 documentation and provides internal control and remediation.
  • Evaluates the current accounting systems to ascertain whether the current programs are adequate, and if appropriate evaluates alternatives and migrates to an improved system.
  • Provides a resource for internal managers and Senior Management regarding the financial implications of operational activities, budget, and reporting issues.
  • Supervises investments and monitoring of corporate funds, directs financial analysis, monitors foreign exchange, and reviews overall corporate cash flow activities.
  • Prepares quarterly reports for Audit Committee Meetings and Board of Director Meetings (when applicable). Directs quarterly Disclosure Committee Meetings.
  • Determines adequacy of insurance coverage for the Company based on discussions with Senior Management and our insurance broker. Supervises the annual insurance applications and submissions for the Company’s insurance coverage programs.
  • Oversees the preparation of the corporate tax returns for Immunomedics, Inc. and IBC Pharmaceuticals (Federal, NJ, and Delaware) by the outside tax consultants, and coordinates with European staff on the German and Netherlands tax returns for Immunomedics GmbH and BV.
  • Develops financial and cash flow forecast analyses as requested by Senior Management for presentation to the Board of Directors. 
  • Directly supervises: Senior Manager, Accounting and Manager, Financial Reporting.


  • Bachelor’s degree in accounting or a related discipline with at least 10 years of related experience and/or training; or equivalent combination of education and experience. 
  • Current CPA designation required with prior public accounting experience.
  • MBA preferred.
  • Pharmaceutical or biotech industry experience required (with internal manufacturing operations) coupled with an understanding of finance and accounting functions within a commercial entity. 
  • Advanced knowledge of GAAP, SEC Reporting, financial reporting and analysis, budgeting, forecasting, income taxes, and insurance. 
  • Knowledge of current financial, accounting, and SEC reporting standards. 
  • Good verbal and written communication skills. 
  • Ability to establish and meet deadlines, handle multiple priorities, and works well under pressure.


Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed